223
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018

, , , &
Pages 539-547 | Received 02 Dec 2017, Accepted 07 Jun 2018, Published online: 04 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xin Zhao, Chenhao Zhang, Yi An, Zixuan Zhang, Jiahe Zhao, Xinwen Zhang, Yue Yang & Wei Cao. (2023) Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents. Journal of Inflammation Research 16, pages 443-452.
Read now

Articles from other publishers (6)

Bernard Calvino. (2023) Inflammation aiguë, inflammation chronique - 4e partie. Pharmacologie inhibitrice des récepteurs de l’IL-6 (IL-6R, sIL-6r et sGP130). Douleurs : Évaluation - Diagnostic - Traitement 24:5-6, pages 266-270.
Crossref
Brittany N. Weber, Jon T. Giles & Katherine P. Liao. (2023) Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease. Nature Reviews Rheumatology 19:7, pages 417-428.
Crossref
Hossam Nada, Aneesh Sivaraman, Qili Lu, Kyoungho Min, Sungdo Kim, Ja-Il Goo, Yongseok Choi & Kyeong Lee. (2023) Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure–Activity Relationships and Molecular Docking. Journal of Medicinal Chemistry.
Crossref
Tiago Borges, Arsénio Barbosa & Sérgio Silva. 2022. Translational Autoimmunity. Translational Autoimmunity 83 114 .
Franco Pandolfi, Laura Franza, Valentina Carusi, Simona Altamura, Gloria Andriollo & Eleonora Nucera. (2020) Interleukin-6 in Rheumatoid Arthritis. International Journal of Molecular Sciences 21:15, pages 5238.
Crossref
Ladislav Senolt. (2019) Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies. F1000Research 8, pages 1549.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.